Rationale and design of ARTS: a randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease

European Journal of Heart Failure
Bertram PittFaiez Zannad

Abstract

BAY 94-8862 is a novel, non-steroidal, mineralocorticoid receptor antagonist with greater selectivity than spironolactone and stronger mineralocorticoid receptor binding affinity than eplerenone. The aims of the MinerAlocorticoid Receptor Antagonist Tolerability Study (ARTS; NCT01345656) are to evaluate the safety and tolerability of BAY 94-8862 in patients with heart failure associated with a reduced left ventricular ejection fraction (HFREF) and chronic kidney disease (CKD), and to examine the effects on biomarkers of cardiac and renal function. Methods ARTS is a multicentre, randomized, double-blind, placebo-controlled, parallel-group study divided into two parts. In part A, oral BAY 94-8862 [2.5, 5, or 10 mg once daily (o.d.)] is compared with placebo in ∼60 patients with HFREF and mild CKD. Outcome measures include serum potassium concentration, biomarkers of renal injury, estimated glomerular filtration rate (eGFR), and albuminuria. Part B compares BAY 94-8862 (2.5, 5, or 10 mg o.d., or 5 mg twice daily), placebo, and open-label spironolactone (25-50 mg o.d.) in ∼360 patients with HFREF and moderate CKD. Outcome measures include the change in serum potassium concentration with BAY 94-8862 vs. placebo (primary endpoint) an...Continue Reading

References

Jul 1, 1975·Endocrinology·P CorvolJ Mahoudeau
Jan 5, 2002·The New England Journal of Medicine·K T Weber
Aug 6, 2002·American Journal of Hypertension·Myron H WeinbergerRobert J Weiss
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
Aug 25, 2006·Nature Clinical Practice. Endocrinology & Metabolism·John W Funder
Jan 25, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Andrew S BombackPhilip J Klemmer
Jun 17, 2008·The Journal of Clinical Endocrinology and Metabolism·John W FunderUNKNOWN Endocrine Society
Mar 6, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Sankar D NavaneethanGiovanni F M Strippoli
Jun 24, 2009·Archives of Internal Medicine·Lisa M EinhornJeffrey C Fink
Sep 5, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Gaurav JainDavid G Warnock
Jul 1, 2008·Circulation. Heart Failure·Gregg C FonarowMary Norine Walsh
Oct 22, 2009·JAMA : the Journal of the American Medical Association·Nancy M AlbertGregg C Fonarow
Apr 23, 2010·Journal of Medicinal Chemistry·Graciela B ArhancetHorng-Chih Huang
Jul 24, 2010·The Journal of Biological Chemistry·Jérôme FagartPeter Kolkhof
Sep 2, 2010·European Journal of Heart Failure·Aldo P MaggioniUNKNOWN Heart Failure Association of ESC (HFA)
Nov 16, 2010·The New England Journal of Medicine·Faiez ZannadUNKNOWN EMPHASIS-HF Study Group
Jun 16, 2011·European Heart Journal·Mazen AlbaghdadiBertram Pitt
Jul 21, 2011·Molecular and Cellular Endocrinology·Peter Kolkhof, Steffen A Borden
Sep 8, 2011·The Journal of Clinical Hypertension·Murray Epstein, David A Calhoun

❮ Previous
Next ❯

Citations

Mar 4, 2014·Current Cardiology Reports·Jamshid Shirani, Vasken Dilsizian
Nov 13, 2013·Expert Opinion on Therapeutic Patents·Matthieu CollinFrédéric Jaisser
Jan 18, 2013·Expert Opinion on Therapeutic Targets·Morag J Young
Dec 5, 2015·European Journal of Heart Failure·Peter BramlageRoland E Schmieder
Jan 28, 2014·European Journal of Heart Failure·Javaid IqbalFaiez Zannad
Mar 25, 2014·Journal of the American College of Cardiology·Erik B SchelbertMihai Gheorghiade
Dec 7, 2014·Expert Opinion on Pharmacotherapy·Elisabeth KaldaraJohn N Nanas
Feb 25, 2015·Trends in Endocrinology and Metabolism : TEM·Yasir ParvizFaiez Zannad
Jun 25, 2014·BioMed Research International·Liviu SegallAdrian Covic
Apr 23, 2016·Expert Opinion on Investigational Drugs·Hao A TranBarry H Greenberg
Aug 11, 2016·Metabolism: Clinical and Experimental·Pingping YangGaosi Xu
Aug 24, 2016·Expert Opinion on Therapeutic Patents·Matthieu Collin, Frédéric Jaisser
Jul 22, 2016·Experimental Biology and Medicine·Anna Gromotowicz-PoplawskaEwa Chabielska
Oct 22, 2013·Circulation. Heart Failure·Helle BosselmannMorten Schou
Mar 15, 2015·Circulation Research·Suzanne Oparil, Roland E Schmieder
Jan 24, 2019·Current Diabetes Reports·Yuliya LytvynDavid Z Cherney
Aug 10, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Andrew A House
Sep 2, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Michael GerischThomas Schwarz
Mar 14, 2014·Journal of Cardiovascular Pharmacology·Peter KolkhofStefan Schäfer
Jul 6, 2014·Current Opinion in Nephrology and Hypertension·James M Luther
Jun 18, 2015·Current Opinion in Nephrology and Hypertension·Peter KolkhofFrank Eitner
Feb 28, 2020·The Cochrane Database of Systematic Reviews·Meaghan LunneyPietro Ravani
Nov 18, 2015·Current Opinion in Nephrology and Hypertension·James M Luther
Oct 16, 2015·Journal of Cardiovascular Pharmacology·Elise Gomez-Sanchez
Mar 3, 2020·Current Hypertension Reports·Daisuke SuetaKenichi Tsujita
May 2, 2014·The Cochrane Database of Systematic Reviews·Davide BolignanoGiovanni F M Strippoli
Jun 29, 2017·Current Heart Failure Reports·Ersilia M DeFilippis, Akshay S Desai
Oct 28, 2020·The Cochrane Database of Systematic Reviews·Edmund Ym ChungGiovanni Fm Strippoli
Oct 8, 2020·Pharmacology & Therapeutics·Cosimo CosimatoThomas A Mavrakanas
Aug 31, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Peter KolkhofUlrich Kintscher
Sep 15, 2021·Drugs·James E Frampton
Oct 2, 2021·Expert Opinion on Investigational Drugs·Bertram PittGeorge Bakris

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.